1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Non-Alcoholic Steatohepatitis Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Non-Alcoholic Steatohepatitis Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Non-Alcoholic Steatohepatitis Market Regional Analysis
6.2 North America Non-Alcoholic Steatohepatitis Market Revenue 2019-2028 (US$ Million)
6.3 North America Non-Alcoholic Steatohepatitis Market Forecast Analysis
7. North America Non-Alcoholic Steatohepatitis Market Analysis – by Product
7.1 Vitamin E and Pioglitazone
- 7.1.1 Overview
- 7.1.2 Vitamin E and Pioglitazone: North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Ocaliva
- 7.2.1 Overview
- 7.2.2 Ocaliva: North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Elafibranor
- 7.3.1 Overview
- 7.3.2 Elafibranor: North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Selonsertib
- 7.4.1 Overview
- 7.4.2 Selonsertib: North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Cenicriviroc
- 7.5.1 Overview
- 7.5.2 Cenicriviroc: North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Non-Alcoholic Steatohepatitis Market Analysis – by Application
8.1 Treatment
- 8.1.1 Overview
- 8.1.2 Treatment: North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Diagnosis
- 8.2.1 Overview
- 8.2.2 Diagnosis: North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Non-Alcoholic Steatohepatitis Market Analysis – by Sales Channel
9.1 Hospital Pharmacy
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacy: North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Online Provider
- 9.2.1 Overview
- 9.2.2 Online Provider: North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Retail Pharmacy
- 9.3.1 Overview
- 9.3.2 Retail Pharmacy : North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Non-Alcoholic Steatohepatitis Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Non-Alcoholic Steatohepatitis Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 North America Non-Alcoholic Steatohepatitis Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Non-Alcoholic Steatohepatitis Market Breakdown, by Product
- 10.2.1.1.2 US: North America Non-Alcoholic Steatohepatitis Market Breakdown, by Application
- 10.2.1.1.3 US: North America Non-Alcoholic Steatohepatitis Market Breakdown, by Sales Channel
- 10.2.1.2 Canada:
North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Non-Alcoholic Steatohepatitis Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Non-Alcoholic Steatohepatitis Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Non-Alcoholic Steatohepatitis Market Breakdown, by Sales Channel
- 10.2.1.3 Mexico :
North America Non-Alcoholic Steatohepatitis Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Non-Alcoholic Steatohepatitis Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Non-Alcoholic Steatohepatitis Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Non-Alcoholic Steatohepatitis Market Breakdown, by Sales Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Cadila Pharmaceutical.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Intercept Pharmaceutical.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Novartis AG.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Galmed Pharmaceutical.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 GENFIT.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Prometheus Laboratories.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Siemens Healthineers AG.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Laboratory Corporation of America Holdings.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Non-Alcoholic Steatohepatitis Market
